424 related articles for article (PubMed ID: 25739373)
1. [Anti-VEGF therapy for neovascular age-related macular degeneration -therapeutic strategies: statement of the German Ophthalmological Society, the German Retina Society and the Professional Association of Ophthalmologists in Germany - November 2014].
Deutsche Ophthalmologische Gesellschaft
Ophthalmologe; 2015 Mar; 112(3):237-45. PubMed ID: 25739373
[No Abstract] [Full Text] [Related]
2. [Statement of the German Ophthalmological Society, the German Retina Society and the Professional Association of German Ophthalmologists: The anti-VEGF therapy in neovascular age-related macular degeneration: Therapeutic Strategies (November 2014)].
Gesellschaft DO
Klin Monbl Augenheilkd; 2015 Feb; 232(2):202-10. PubMed ID: 25700258
[No Abstract] [Full Text] [Related]
3. Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.
Moon DRC; Lee DK; Kim SH; You YS; Kwon OW
Korean J Ophthalmol; 2015 Aug; 29(4):226-32. PubMed ID: 26240506
[TBL] [Abstract][Full Text] [Related]
4. Influence of Vitreomacular Adhesion on Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration.
Kanadani TCM; Dos Reis Veloso CE; Dorairaj S; Nehemy MB
Ophthalmic Res; 2017; 58(1):18-26. PubMed ID: 28301850
[TBL] [Abstract][Full Text] [Related]
5. Association of Early Anatomic Response with Visual Function in Neovascular Age-Related Macular Degeneration.
Singer M; Singh RP; Gibson A; Moini H; Reed K; Vitti R; Du W; Eichenbaum D
Ophthalmology; 2021 Nov; 128(11):1657-1660. PubMed ID: 34019956
[No Abstract] [Full Text] [Related]
6. Switch to aflibercept or ranibizumab after initial treatment with bevacizumab in eyes with neovascular AMD.
Waizel M; Todorova MG; Masyk M; Wolf K; Rickmann A; Helaiwa K; Blanke BR; Szurman P
BMC Ophthalmol; 2017 May; 17(1):79. PubMed ID: 28535756
[TBL] [Abstract][Full Text] [Related]
7. Inner retinal layer change in glaucoma patients receiving anti-VEGF for neovascular age related macular degeneration.
Saleh R; Karpe A; Zinkernagel MS; Munk MR
Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):817-824. PubMed ID: 28127658
[TBL] [Abstract][Full Text] [Related]
8. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment
Witkin AJ; Rayess N; Garg SJ; Maguire JI; Storey P; Kaiser RS; Hsu J; Vander JF; Ho AC
Semin Ophthalmol; 2017; 32(3):309-315. PubMed ID: 26337539
[TBL] [Abstract][Full Text] [Related]
9. [Retrospective investigation of anti-VEGF treatment reality and effectiveness in patients with neovascular age-related macular degeneration (AMD) in Germany: treatment reality of ranibizumab for neovascular AMD in Germany].
Ziemssen F; Eter N; Fauser S; Bopp S; Radermacher M; Hasanbasic Z; Holz FG;
Ophthalmologe; 2015 Mar; 112(3):246-54. PubMed ID: 25668709
[TBL] [Abstract][Full Text] [Related]
10. [Change of therapy from ranibizumab to aflibercept for recurrent or persistent exudative age-related macular degeneration].
Ziegler M; Heimes B; Book B; Dietzel M; Zeimer M; Spital G; Gutfleisch M; Pauleikhoff D; Lommatzsch A
Ophthalmologe; 2015 May; 112(5):435-43. PubMed ID: 25523611
[TBL] [Abstract][Full Text] [Related]
11. Switching to aflibercept in patients with neovascular age-related macular degeneration not responding to bevacizumab: a pilot study.
van Asten F; Klevering BJ; Hoyng CB
Acta Ophthalmol; 2017 Aug; 95(5):e426-e427. PubMed ID: 27350361
[No Abstract] [Full Text] [Related]
12. Anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration: Comparison of Age-related Macular Degeneration Treatments Trials 5 year outcomes and implication for clinical practice.
Chong EW; Al-Qureshi SH
Clin Exp Ophthalmol; 2017 May; 45(4):333-335. PubMed ID: 28618455
[No Abstract] [Full Text] [Related]
13. Cost-effectiveness of treating wet age-related macular degeneration at the Kuopio University Hospital in Finland based on a two-eye Markov transition model.
Vottonen P; Kankaanpää E
Acta Ophthalmol; 2016 Nov; 94(7):652-656. PubMed ID: 27481048
[TBL] [Abstract][Full Text] [Related]
14. Neovascular Age-Related Macular Degeneration Disease Quiescence with Visual Acuity Stability in a Subgroup of Patients Following PRN Treatment.
Fliney GD; Zukin LM; Hagedorn C
J Ocul Pharmacol Ther; 2017 Oct; 33(8):604-609. PubMed ID: 28829220
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes in eyes receiving fixed-interval dosing of anti-vascular endothelial growth factor agents for wet age-related macular degeneration.
Peden MC; Suñer IJ; Hammer ME; Grizzard WS
Ophthalmology; 2015 Apr; 122(4):803-8. PubMed ID: 25596618
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of outer retinal tubulations in eyes switched from intravitreal ranibizumab to aflibercept for treatment of exudative age-related macular degeneration.
Massamba N; Dirani A; Butel N; Fardeau C; Bodaghi B; Ingram A; Lehoang P
Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):61-67. PubMed ID: 27397583
[TBL] [Abstract][Full Text] [Related]
17. [Real life visual and anatomic outcomes of aflibercept treatment for treatment-naive patients with exudative age-related macular degeneration].
Duval MV; Rougier MB; Delyfer MN; Combillet F; Korobelnik JF
J Fr Ophtalmol; 2017 Apr; 40(4):270-278. PubMed ID: 28341388
[TBL] [Abstract][Full Text] [Related]
18. [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists therapy for choroidal neovascularization in myopia ].
Pauleikhoff D; Bertram B; Claessens D; ; ;
Klin Monbl Augenheilkd; 2014 May; 231(5):548-53. PubMed ID: 24799174
[No Abstract] [Full Text] [Related]
19. Arteriosclerotic Changes after Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Drugs in Patients with Exudative Age-Related Macular Degeneration.
Shiba T; Takahashi M; Yoshida I; Taniguchi H; Matsumoto T; Hori Y
Ophthalmologica; 2016; 235(4):225-32. PubMed ID: 27082736
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of anti-vascular endothelial growth factor injections on intraocular pressure.
Nariani A; Williams B; Hariprasad SM
Indian J Ophthalmol; 2016 Sep; 64(9):643-647. PubMed ID: 27853011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
